The objective of this study was to demonstrate the impact of a single ICD-9 (International Statistical Classification of Diseases and Related Health Problems, Version 9) code on the observed-to-expected mortality ratios for acute care hospitals, calculated using administrative data. The study was a retrospective analysis of mortality data and prospective measurement of the impact of a change in coding on expected mortality rates. Measurement included overall mortality observed-to-expected mortality index for 2 hospitals and rate of use of the palliative care ICD-9 code. The main result was that both retrospective and prospective applications of this single ICD-9 code significantly reduced observed-to-expected mortality ratios. Both regulators and hospitals need to be aware of the impact of the quality of coding on publicly reported quality and patient safety data.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1062860609357467 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
External validation of EuroSCORE I and II in patients with infective endocarditis: results from a nationwide prospective registry.
Eur J Cardiothorac Surg
November 2024
Department of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands.
Objectives: The primary objective was to externally validate EuroSCORE I and II in surgically treated endocarditis patients. The secondary objective was to assess the predictive performance of both models across sex, redo surgery, age, and urgency.
Methods: Data were retrieved from the Netherlands Heart Registration.
External validation of SCORE2-Diabetes in the Netherlands across various Socioeconomic levels in native-Dutch and non-Dutch populations.
Eur J Prev Cardiol
November 2024
Department of Public Health and Primary Care/Health Campus the Hague, Leiden University Medical Center (LUMC), the Netherlands.
Aims: Adults with type 2 diabetes have an increased risk of cardiovascular events (CVE), the world's leading cause of mortality. The SCORE2-Diabetes model is a tool designed to estimate the 10-year risk of CVE specifically in individuals with type 2 diabetes. However, the performance of such models may vary across different demographic and socioeconomic groups, necessitating validation and assessment in diverse populations.
View Article and Find Full Text PDFThyroid Cancer Incidence During 2020 to 2021 COVID-19 Variant Waves.
JAMA Otolaryngol Head Neck Surg
October 2024
The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, Vermont.
Importance: How rates of thyroid cancer diagnosis were affected by the emergence of COVID-19 variants during the 2020 to 2021 era of the pandemic has not been described.
Objective: To estimate the total number of undiagnosed cases of thyroid cancer, by histologic type, during the first 2 years of the COVID-19 pandemic (2020 and 2021) by comparing observed to expected incidence and to test for changes in size of cancer at incidence during the same period compared to prior years.
Design, Setting, And Participants: This longitudinal study analyzed trends in thyroid cancer diagnoses from 2016 to 2021 among US adults using data from the Surveillance, Epidemiology, and End Results 22 (SEER-22) program database.
Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic.
JAMA Netw Open
October 2024
Yale New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut.
Article Synopsis
- The research highlights significant racial and ethnic disparities in excess mortality during the COVID-19 pandemic, revealing a concerning trend concerning minoritized populations who faced greater mortality rates compared to pre-pandemic disparities.!* -
- A comprehensive analysis of over 10.6 million death certificates from March 2020 to May 2023 indicated that more than 1.38 million excess deaths occurred, representing around 23 million years of potential life lost.!* -
- The findings emphasize the need for further investigation into the age-specific impact of COVID-19 on various racial and ethnic groups to better understand and address these health disparities moving forward.!*
Health system resilience during the COVID-19 pandemic: A comparative analysis of disruptions in care from 32 countries.
Health Serv Res
December 2024
Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
Objective: To quantify disruptions in hospitalization and ambulatory care throughout the coronavirus disease 2019 (COVID-19) pandemic for 32 countries, and examine associations of health system characteristics and COVID-19 response strategies on disruptions.
Data Sources: We utilized aggregated inpatient hospitalization and surgical procedure data from the Organization for Economic Co-operation and Development Health Database from 2010 to 2021. Covariate data were extracted from the Organization for Economic Co-operation and Development Health Database, World Health Organization, and Oxford COVID-19 Government Response Tracker.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!